Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DaVita Inc V.DVA


Primary Symbol: DVA

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.


NYSE:DVA - Post by User

Post by Voteliberalon Apr 21, 2017 2:05pm
145 Views
Post# 26149952

tweed on main street

tweed on main streetI see this product being branded on tweed on mainstreet just like FORIA. under Delivra brand. 
by fall!!

"Canadian medical marijuana patients could soon find themselves ditching the pipe, bong or vaporizer for a topical cream or an oral spray that contains the active ingredients of cannabis, according to the CEO of biotechnology company Delivra Corp.

There are a number of problems with the current methods of ingesting marijuana says Delivra’s Joseph Gabriele.

Smoking it can be bad for the lungs, while edibles can take an hour or even longer to take effect, says Gabriele.

That’s why Delivra decided to start looking into using their existing transdermal drug delivery system, which allows drugs to be absorbed through the skin, for medical cannabis.

The company has partnered with ARA-Avanti Rx Analytics Inc. and Dosecann Inc. to develop the product and is aiming to launch it in the fourth quarter of 2017"

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse